These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36703790)

  • 1. MIF promotes cell invasion by the LRP1-uPAR interaction in pancreatic cancer cells.
    Sun H; Cheng R; Zhang D; Guo Y; Li F; Li Y; Li Y; Bai X; Mo J; Huang C
    Front Oncol; 2022; 12():1028070. PubMed ID: 36703790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A; Xue M; Jackson C; Smith RC
    Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of macrophage migration inhibitory factor promotes tumor metastasis and correlates with poor prognosis of pancreatic ductal adenocarcinoma.
    Wang D; Wang R; Huang A; Fang Z; Wang K; He M; Xia JT; Li W
    Oncol Rep; 2018 Nov; 40(5):2628-2636. PubMed ID: 30226561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase-Type Plasminogen Activator Receptor (uPAR) Cooperates with Mutated
    Peng L; Li Y; Yao S; Gaedcke J; Baart VM; Sier CFM; Neesse A; Ellenrieder V; Bohnenberger H; Fuchs F; Kitz J; Ströbel P; Küffer S
    Cancers (Basel); 2023 Mar; 15(5):. PubMed ID: 36900379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2.
    Yang S; He P; Wang J; Schetter A; Tang W; Funamizu N; Yanaga K; Uwagawa T; Satoskar AR; Gaedcke J; Bernhardt M; Ghadimi BM; Gaida MM; Bergmann F; Werner J; Ried T; Hanna N; Alexander HR; Hussain SP
    Cancer Res; 2016 Jul; 76(13):3838-50. PubMed ID: 27197190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-dopachrome tautomerase is over-expressed in pancreatic ductal adenocarcinoma and acts cooperatively with macrophage migration inhibitory factor to promote cancer growth.
    Guo D; Guo J; Yao J; Jiang K; Hu J; Wang B; Liu H; Lin L; Sun W; Jiang X
    Int J Cancer; 2016 Nov; 139(9):2056-67. PubMed ID: 27434219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia Promotes Extravillous Trophoblast Cell Invasion through the Hypoxia-Inducible Factor Urokinase-Type Plasminogen Activator Receptor Pathway.
    Shigemitsu A; Naruse K; Kobayashi H
    Gynecol Obstet Invest; 2022; 87(3-4):232-241. PubMed ID: 35785760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
    McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S
    Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
    Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
    Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia inducible factor-1 mediates upregulation of urokinase-type plasminogen activator receptor gene transcription during hypoxia in cervical cancer cells.
    Nishi H; Sasaki T; Nagamitsu Y; Terauchi F; Nagai T; Nagao T; Isaka K
    Oncol Rep; 2016 Feb; 35(2):992-8. PubMed ID: 26718775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-inducible factor-1 promotes pancreatic ductal adenocarcinoma invasion and metastasis by activating transcription of the actin-bundling protein fascin.
    Zhao X; Gao S; Ren H; Sun W; Zhang H; Sun J; Yang S; Hao J
    Cancer Res; 2014 May; 74(9):2455-64. PubMed ID: 24599125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.
    Magnussen SN; Hadler-Olsen E; Costea DE; Berg E; Jacobsen CC; Mortensen B; Salo T; Martinez-Zubiaurre I; Winberg JO; Uhlin-Hansen L; Svineng G
    BMC Cancer; 2017 May; 17(1):350. PubMed ID: 28526008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA.
    He X; Zheng Z; Li J; Ben Q; Liu J; Zhang J; Ji J; Yu B; Chen X; Su L; Zhou L; Liu B; Yuan Y
    Carcinogenesis; 2012 Mar; 33(3):555-62. PubMed ID: 22223849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the urokinase receptor (uPAR) by LDL receptor-related protein-1 (LRP1).
    Gonias SL; Gaultier A; Jo M
    Curr Pharm Des; 2011; 17(19):1962-9. PubMed ID: 21711236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes.
    Wang X; Ren H; Zhao T; Ma W; Dong J; Zhang S; Xin W; Yang S; Jia L; Hao J
    Oncotarget; 2016 Mar; 7(12):13717-29. PubMed ID: 26872370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
    BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis.
    Tiwari A; Tashiro K; Dixit A; Soni A; Vogel K; Hall B; Shafqat I; Slaughter J; Param N; Le A; Saunders E; Paithane U; Garcia G; Campos AR; Zettervall J; Carlson M; Starr TK; Marahrens Y; Deshpande AJ; Commisso C; Provenzano PP; Bagchi A
    Gastroenterology; 2020 Nov; 159(5):1882-1897.e5. PubMed ID: 32768595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MIF confers survival advantage to pancreatic CAFs by suppressing interferon pathway-induced p53-dependent apoptosis.
    Suresh V; Dash P; Suklabaidya S; Murmu KC; Sasmal PK; Jogdand GM; Parida D; Sethi M; Das B; Mohapatra D; Saha S; Prasad P; Satoskar A; Senapati S
    FASEB J; 2022 Aug; 36(8):e22449. PubMed ID: 35839070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic stromal Gremlin 1 expression during pancreatic tumorigenesis.
    Davis JM; Cheng B; Drake MM; Yu Q; Yang B; Li J; Liu C; Younes M; Zhao X; Bailey JM; Shen Q; Ko TC; Cao Y
    Genes Dis; 2022 Jan; 9(1):108-115. PubMed ID: 35005111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nicotine-induced positive feedback loop between HIF1A and YAP1 contributes to epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma.
    Ben Q; An W; Sun Y; Qian A; Liu J; Zou D; Yuan Y
    J Exp Clin Cancer Res; 2020 Sep; 39(1):181. PubMed ID: 32894161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.